Serum IgG from children with OMS and NB potentiates microglial activation, which induces neuronal cytolysis through the NO/sGC/PKG pathway, suggesting an applicability of microglial inhibitor as a therapeutic candidate. The gene discussed is PRKG1; the disease is opsoclonus-myoclonus syndrome.